Mahajan, Anubha, Taliun, Daniel, Thurner, Matthias, Robertson, Neil R, Torres, Jason M, Rayner, N William, Payne, Anthony J, Steinthorsdottir, Valgerdur, Scott, Robert A, Grarup, Niels et al (show 105 more authors)
(2018)
Fine-mapping type 2 diabetes loci to single-variant resolution using high-density imputation and islet-specific epigenome maps.
NATURE GENETICS, 50 (11).
pp. 1505-1513.
![]() |
Text
Main text NG-A47886R final.pdf - Author Accepted Manuscript Download (1MB) |
![]() |
Text
3. Integrated Supplementary Figures.pdf - Author Accepted Manuscript Download (1MB) |
![]() |
Text
4. Supplementary Notes.pdf - Author Accepted Manuscript Download (555kB) |
![]() |
Spreadsheet
4. Supplementary Tables NG-A47886R.xlsx - Author Accepted Manuscript Download (252kB) |
![]() |
Text
Figure 1.pdf - Author Accepted Manuscript Download (291kB) |
![]() |
Text
Figure 2.pdf - Author Accepted Manuscript Download (130kB) |
![]() |
Text
Figure 3.pdf - Author Accepted Manuscript Download (89kB) |
![]() |
Text
Figure 4.pdf - Author Accepted Manuscript Download (39kB) |
![]() |
Text
Figure 5.pdf - Author Accepted Manuscript Download (64kB) |
![]() |
Text
Figure 6.pdf - Author Accepted Manuscript Download (730kB) |
Abstract
We expanded GWAS discovery for type 2 diabetes (T2D) by combining data from 898,130 European-descent individuals (9% cases), after imputation to high-density reference panels. With these data, we (i) extend the inventory of T2D-risk variants (243 loci, 135 newly implicated in T2D predisposition, comprising 403 distinct association signals); (ii) enrich discovery of lower-frequency risk alleles (80 index variants with minor allele frequency <5%, 14 with estimated allelic odds ratio >2); (iii) substantially improve fine-mapping of causal variants (at 51 signals, one variant accounted for >80% posterior probability of association (PPA)); (iv) extend fine-mapping through integration of tissue-specific epigenomic information (islet regulatory annotations extend the number of variants with PPA >80% to 73); (v) highlight validated therapeutic targets (18 genes with associations attributable to coding variants); and (vi) demonstrate enhanced potential for clinical translation (genome-wide chip heritability explains 18% of T2D risk; individuals in the extremes of a T2D polygenic risk score differ more than ninefold in prevalence).
Item Type: | Article |
---|---|
Uncontrolled Keywords: | Islets of Langerhans, Humans, Diabetes Mellitus, Type 2, Genetic Predisposition to Disease, Body Mass Index, Case-Control Studies, Chromosome Mapping, Sex Factors, Epigenesis, Genetic, Gene Frequency, Linkage Disequilibrium, Polymorphism, Single Nucleotide, Genome, Human, Female, Male, Meta-Analysis as Topic, Genome-Wide Association Study, Genetic Loci, High-Throughput Screening Assays, White People |
Depositing User: | Symplectic Admin |
Date Deposited: | 15 Oct 2018 14:27 |
Last Modified: | 19 Jan 2023 01:14 |
DOI: | 10.1038/s41588-018-0241-6 |
Related URLs: | |
URI: | https://livrepository.liverpool.ac.uk/id/eprint/3027479 |